Shanghai Pharmaceuticals : to Buy Cardinal Health’s Unit for US$557 Million

Shanghai Pharmaceuticals Holding Co. (2607.HK) plans to buy the pharmaceutical distribution network of U.S. company Cardinal Health Inc. in Hong Kong and mainland China for US$557 million. The Hong Kong listed pharmaceutical company said Wednesday that it …
( read original story …)

Related Post